January 6, 2021

American CryoStem Enters into a Cooperative Research and Development Agreement (CRADA) to Develop Standardized Treatment Protocols

December 1, 2020

American CryoStem Announces Patient Recruitment and Additional Sub-Investigator for its Post-Concussion Syndrome (PCS) Phase I Clinical Trial

September 23, 2020

American CryoStem Announces: FDA has cleared its Investigational New Drug (IND) for Post-Concussion Syndrome for Phase I Clinical Trial

June 29, 2020

American CryoStem Announces the Conversion of Debenture into Equity and Sale into the Market

April 2, 2020

American CryoStem to Develop ATCELL™ Clinical Study for Duchene Muscular Dystrophy with RACEMD

December 5, 2019

American CryoStem Corporation Issues Shareholder Letter

October 3, 2019

American CryoStem Announces:  American CryoStem Expands Investigator Team with Sub-Investigators for Post Concussive Syndrome IND

September 18, 2019

American CryoStem Announces:  FDA Accepted its Investigational New Drug Application for Post Concussion Syndrome

September 12, 2019

American CryoStem Engages BioSolutions Clinical Research Center, LLC. and Principal Investigator for Chronic Concussive Syndrome IND